Weighted Average Number of Shares Outstanding, Basic of DMK PHARMACEUTICALS Corp from 31 Mar 2013 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
DMK PHARMACEUTICALS Corp quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2013 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 7,065,673, a 230% increase year-over-year.
  • DMK PHARMACEUTICALS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 149,851,278, a 4% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 144,157,229.
  • DMK PHARMACEUTICALS Corp annual Weighted Average Number of Shares Outstanding, Basic for 2016 was 17,500,827, a 32% increase from 2015.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

DMK PHARMACEUTICALS Corp Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 7,065,673 +4,923,055 +230% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 2,569,400 +429,176 +20% 01 Apr 2023 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 152,916,598 +3,299,169 +2.2% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 149,851,278 +5,694,049 +4% 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
Q3 2022 2,142,618 -146,743,523 -99% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 2,140,224 -146,745,917 -99% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 149,617,429 +20,153,562 +16% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 144,157,229 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 148,886,141 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 148,886,141 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 129,463,867 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2016 17,500,827 +4,224,980 +32% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
Q3 2016 19,606,190 +6,185,542 +46% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 15,373,510 +1,957,590 +15% 01 Apr 2016 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 13,444,500 +616,376 +4.8% 01 Jan 2016 31 Mar 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 13,275,847 +2,784,169 +27% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 13,420,648 +2,906,120 +28% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 13,415,920 +2,915,577 +28% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 12,828,124 +2,443,204 +24% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1
Q4 2014 10,491,678 01 Oct 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q3 2014 10,514,528 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 10,500,343 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 10,384,920 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1

DMK PHARMACEUTICALS Corp Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 149,851,278 +5,694,049 +4% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 144,157,229 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2016 17,500,827 +4,224,980 +32% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
2015 13,275,847 +2,784,169 +27% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 10,491,678 +3,145,523 +43% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
2013 7,346,155 +1,487,358 +25% 01 Apr 2013 31 Mar 2014 10-KT 26 Mar 2015 2014 FY
2012 5,858,797 01 Apr 2012 31 Mar 2013 10-K 23 Jun 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.